The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability

Kakkos, 2007, Texture analysis of ultrasonic images of symptomatic carotid plaques can identify those plaques associated with ipsilateral embolic brain infarction, Eur J Vasc Endovasc Surg, 33, 422, 10.1016/j.ejvs.2006.10.018 Nighoghossian, 2005, The vulnerable carotid artery plaque: current imaging methods and new perspectives, Stroke, 36, 2764, 10.1161/01.STR.0000190895.51934.43 Liapis, 2001, Carotid stenosis: factors affecting symptomatology, Stroke, 32, 2782, 10.1161/hs1201.099797 Grogan, 2005, B-mode ultrasonographic characterization of carotid atherosclerotic plaques in symptomatic and asymptomatic patients, J Vasc Surg, 42, 435, 10.1016/j.jvs.2005.05.033 Johnson, 2006, Vascular calcification: pathobiological mechanisms and clinical implications, Circ Res, 99, 1044, 10.1161/01.RES.0000249379.55535.21 Shaalan, 2004, Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation, J Vasc Surg, 40, 262, 10.1016/j.jvs.2004.04.025 Raggi, 2003, Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction, Am J Cardiol, 92, 827, 10.1016/S0002-9149(03)00892-0 Ehara, 2004, Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study, Circulation, 110, 3424, 10.1161/01.CIR.0000148131.41425.E9 Denhardt, 2001, Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival, J Clin Invest, 107, 1055, 10.1172/JCI12980 Abedin, 2004, Vascular calcification: mechanisms and clinical ramifications, Arterioscler Thromb Vasc Biol, 24, 1161, 10.1161/01.ATV.0000133194.94939.42 O’Brien, 1994, Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques, Arterioscler Thromb, 14, 1648, 10.1161/01.ATV.14.10.1648 Schoppet, 2002, RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function, Arterioscler Thromb Vasc Biol, 22, 549, 10.1161/01.ATV.0000012303.37971.DA Hofbauer, 2001, Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells, Biochem Biophys Res Commun, 280, 334, 10.1006/bbrc.2000.4130 Jono, 2002, Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease, Circulation, 106, 1192, 10.1161/01.CIR.0000031524.49139.29 Kiechl, 2004, Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease, Circulation, 109, 2175, 10.1161/01.CIR.0000127957.43874.BB Grant, 2003, Carotid artery stenosis: gray-scale and Doppler US diagnosis–Society of Radiologists in Ultrasound Consensus Conference, Radiology, 229, 340, 10.1148/radiol.2292030516 Stoitsis, 2006, A modular software system to assist interpretation of medical images – application to vascular ultrasound images, IEEE Trans Instrum Meas, 55, 1944, 10.1109/TIM.2006.884348 Elatrozy, 1998, The effect of B-mode ultrasonic image standardization of the echodensity of symptomatic and asymptomatic carotid bifurcation plaque, Int Angiol, 7 Ohmori, 2003, Plasma osteopontin levels are associated with the presence and extent of coronary artery disease, Atherosclerosis, 170, 333, 10.1016/S0021-9150(03)00298-3 Kurata, 2006, Osteopontin and carotid atherosclerosis in patients with essential hypertension, Clin Sci (Lond), 111, 319, 10.1042/CS20060074 Chiba, 2002, Development of atherosclerosis in osteopontin transgenic mice, Heart Vessels, 16, 111, 10.1007/s003800200005 Matsui, 2003, Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice, Arterioscler Thromb Vasc Biol, 23, 1029, 10.1161/01.ATV.0000074878.29805.D0 Ashkar, 2000, Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity, Science, 287, 860, 10.1126/science.287.5454.860 Li, 2007, Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation, Biochem Biophys Res Commun, 356, 13, 10.1016/j.bbrc.2007.02.092 Golledge, 2004, Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis, Stroke, 35, 1636, 10.1161/01.STR.0000129790.00318.a3 Isoda, 2002, Osteopontin plays an important role in the development of medial thickening and neointimal formation, Circ Res, 91, 77, 10.1161/01.RES.0000025268.10302.0C Kadoglou, 2005, Matrix metalloproteinases and diabetic vascular complications, Angiology, 56, 173, 10.1177/000331970505600208 Tureyen, 2006, Increased angiogenesis and angiogenic gene expression in carotid artery plaques from symptomatic stroke patients, Neurosurgery, 58, 971, 10.1227/01.NEU.0000210246.61817.FE Browner, 2001, Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women, J Clin Endocrinol Metab, 86, 631 Vik, 2007, Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans, Atherosclerosis, 191, 128, 10.1016/j.atherosclerosis.2006.03.002 Kim, 2005, Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity, Clin Endocrinol (Oxf), 63, 594, 10.1111/j.1365-2265.2005.02390.x Anand, 2006, The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects, J Am Coll Cardiol, 47, 1850, 10.1016/j.jacc.2005.12.054 Bucay, 1998, Osteoprotegerin deficient mice develop early onset osteoporosis and arterial calcification, Genes Dev, 12, 1260, 10.1101/gad.12.9.1260 Min, 2000, Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis, J Exp Med, 192, 463, 10.1084/jem.192.4.463 Menke, 2007, Measures of adiposity and cardiovascular disease risk factors, Obesity (Silver Spring), 15, 785, 10.1038/oby.2007.593 Guzik, 2006, Adipocytokines - novel link between inflammation and vascular function?, J Physiol Pharmacol, 57, 505 De Michele, 2002, Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women, Stroke, 33, 2923, 10.1161/01.STR.0000038989.90931.BE Bidder, 2002, Osteopontin transcription in aortic vascular smooth muscle cells is controlled by glucose-regulated upstream stimulatory factor and activator protein-1 activities, J Biol Chem, 277, 44485, 10.1074/jbc.M206235200 Takemoto, 2000, Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis, Arterioscler Thromb Vasc Biol, 20, 624, 10.1161/01.ATV.20.3.624 Ravipati, 2006, Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins, Am J Cardiol, 98, 1170, 10.1016/j.amjcard.2006.06.009